All news

30 September 2026

Grindr makes its first big acquisition, a $250 million bet on HIV prevention telehealth

Grindr is buying PurposeMed, owner of HIV-prevention telehealth provider Freddie, for $250 million in cash and stock, pushing the dating app further into health care.

Grindr, the LGBTQ-focused dating app, wants to be more than a dating app. On Wednesday it agreed to buy PurposeMed, the parent of Freddie, an online clinic that prescribes PrEP. PrEP, short for pre-exposure prophylaxis, is a medication that cuts the risk of getting HIV from sex by 99% when taken as prescribed.

What happened

Grindr will pay $190 million in cash and $60 million in its own shares, for $250 million in total. Up to $70 million more in cash could follow in 2028 if Freddie hits performance goals in 2027. The deal is expected to close in the fourth quarter and is Grindr's first major acquisition since it was founded in 2009.

Freddie started in Canada in 2020, moved into the US in 2024 and now covers all 50 states plus Washington, D.C. It has treated more than 55,000 patients across the two countries, handling video visits, testing, prescriptions and delivery. Grindr plans to plug all of that into its app, so users can learn about PrEP, check insurance coverage, see a clinician and manage refills in one place. It already runs its own health platform, Woodwork, launched in 2025.

CEO George Arison told CNBC that building the same business from scratch would have taken two to three years, because it needs pharmacies and clinicians as well as software.

The numbers behind the bet

Grindr expects the combined US telehealth and pharmacy business to bring in more than $400 a month per active patient, or more than $4,800 a year for someone who stays in care all year. At 50,000 US patients, Arison estimates that adds up to about $240 million a year. For scale, Grindr's revenue over the twelve months to June was about $510 million, according to its filings on Noorult.

The audience is already on the app. Grindr says about 400,000 US users list PrEP on their profiles, and it believes more than two million others could benefit from it.

There is a cost. Grindr says the deal should add to EBITDA (earnings before interest, taxes, depreciation and amortization, a rough measure of operating profit) right away, but that building out the US operation will weigh on its profit margins at first. Arison expects margins to improve with scale and eventually approach the more than 40% its core business earns.

What to watch

  • The details on how much Grindr will invest in the health business, which it plans to share with shareholders in November.
  • Whether the deal closes in the fourth quarter as expected.
  • How quickly patient numbers grow once the service sits inside the app.

Grindr shares closed at $15.43 on Wednesday. Its full financials are on its Noorult company page.

The companies in this story

Based on reporting by CNBC: Grindr expands beyond dating with $250 million PurposeMed acquisition. Facts, not advice.

More news